Autonomix Medical, Inc. (NASDAQ:AMIX) to Present at Integrous Big Hearts, Big Ideas Virtual Investor Conference
Webcast presentation on Wednesday, February 14th at 10:30 AM EST
THE WOODLANDS, TX / ACCESSWIRE / February 9, 2024 / Autonomix Medical, Inc. (NASDAQ:AMIX) (“Autonomix” or the “Company”), a medical device company focused on advancing innovative technologies to revolutionize how diseases involving the nervous system are diagnosed and treated, today announced that Lori Bisson, Chief Executive Officer of Autonomix, will present at Integrous Communications’ Big Hearts, Big Ideas Virtual Investor Conference on Wednesday, February 14, 2024 at 10:30 AM EST.
In addition to the presentation, management will also be available to participate in virtual one-on-one meetings with qualified members of the investor community who are registered to attend the conference. To schedule a meeting with Autonomix, please request through the conference website.
A video webcast of the presentation will be available on the conference website and on the Events page under the Investors section of the Company’s website (autonomix.com). A webcast replay will be available following the live event and will be accessible for 1 year.
To register for the event, Investors can go to the conference link: Big Hearts, Big Ideas Growth Virtual Conference.
About Autonomix Medical, Inc.
Autonomix is a medical device company focused on advancing innovative technologies to revolutionize how diseases involving the nervous system are diagnosed and treated. The Company’s first-in-class technology platform includes a catheter-based microchip sensing array that has the ability to detect and differentiate neural signals with approximately 3,000 times greater sensitivity than currently available technologies. We believe this will enable, for the first time ever, transvascular diagnosis and treatment of diseases involving the peripheral nervous system virtually anywhere in the body.
We are initially developing our technology for pancreatic cancer pain, a condition that can cause debilitating pain and needs an effective solution. However, our technology constitutes a platform with the potential to address dozens of indications, including in cardiology, renal denervation and chronic pain management across a wide disease spectrum.
For more information, visit autonomix.com and connect with the Company on X, LinkedIn, Instagram and Facebook.
About the Integrous Big Hearts, Big Ideas Growth Conference
Welcome to the 2024 Integrous Big Hearts, Big Ideas Growth Virtual Conference, where the nexus of innovation, big investment ideas and charitable giving all converge in a dynamic digital space.
The focus of this conference is to present smaller market cap companies that we believe are poised to be much bigger due to innovation, positioning, and increased visibility.
At the same time, we want to demonstrate compassion and realize that while we can pursue profits in our portfolios, giving back pays dividends in ways that benefit humanity and society. We truly believe that the two do go hand in hand.
Step into the future with us at the 2024 Integrous Big Hearts, Big Ideas Growth Conference, an unparalleled gathering where the pulse of innovation harmonizes with the rhythm of investment and charitable giving on a virtual platform.
Our carefully curated agenda features thought leaders, industry pioneers, and visionaries who will share insights on the latest trends, disruptive technologies, and emerging market dynamics that are shaping the future.
The conference will consist of company presentations (Public, and a select few Private), 1×1’s, as well as presentations from some selected charities that we would like to highlight.
As we navigate the intersection of innovation, investment and giving, the conference aims to spark opportunities for growth. Join us in this digital format where ideas take flight, investments find purpose, and the future unfolds in real-time.
Welcome to a revolution in connectivity, where the 2024 Integrous Big Hearts, Big Ideas Growth Conference sets the stage for a new era of investment, inspiration, and progress.
For further event information:
Autonomix Investor and Media Contact
JTC Team, LLC
Jenene Thomas
833-475-8247
autonomix@jtcir.com
SOURCE: Autonomix Medical, Inc.
View the original press release on accesswire.com
